- Home
- ELTX vs CMBM Comparison
ELTX vs CMBM Comparison
Compare ELTX & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- CMBM
- Stock Information
- Founded
- ELTX 2011
- CMBM 2011
- Country
- ELTX United States
- CMBM United States
- Employees
- ELTX N/A
- CMBM N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- ELTX Health Care
- CMBM Technology
- Exchange
- ELTX Nasdaq
- CMBM Nasdaq
- Market Cap
- ELTX 49.7M
- CMBM 50.8M
- IPO Year
- ELTX 2021
- CMBM 2019
- Fundamental
- Price
- ELTX $4.93
- CMBM $1.18
- Analyst Decision
- ELTX Strong Buy
- CMBM Strong Buy
- Analyst Count
- ELTX 3
- CMBM 3
- Target Price
- ELTX $9.50
- CMBM $5.50
- AVG Volume (30 Days)
- ELTX 28.6K
- CMBM 95.2K
- Earning Date
- ELTX 11-13-2024
- CMBM 11-07-2024
- Dividend Yield
- ELTX N/A
- CMBM N/A
- EPS Growth
- ELTX N/A
- CMBM N/A
- EPS
- ELTX N/A
- CMBM N/A
- Revenue
- ELTX N/A
- CMBM $172,215,000.00
- Revenue This Year
- ELTX N/A
- CMBM N/A
- Revenue Next Year
- ELTX N/A
- CMBM $18.55
- P/E Ratio
- ELTX N/A
- CMBM N/A
- Revenue Growth
- ELTX N/A
- CMBM N/A
- 52 Week Low
- ELTX $2.96
- CMBM $1.06
- 52 Week High
- ELTX $11.45
- CMBM $6.50
- Technical
- Relative Strength Index (RSI)
- ELTX 50.12
- CMBM 44.10
- Support Level
- ELTX $4.95
- CMBM $1.07
- Resistance Level
- ELTX $5.48
- CMBM $1.29
- Average True Range (ATR)
- ELTX 0.32
- CMBM 0.10
- MACD
- ELTX 0.00
- CMBM 0.00
- Stochastic Oscillator
- ELTX 27.27
- CMBM 27.27
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.